Cargando…
Multilevel Botulinum Toxin Type A as a Treatment for Spasticity in Children with Cerebral Palsy: A Retrospective Study
INTRODUCTION: Cerebral palsy is the most common cause of physical disability in children. Spasticity is a disabling clinical symptom that is prevalent among patients suffering from cerebral palsy. The treatment of spasticity with botulinum toxin type A (BTX-A) is a well-established option in the int...
Autores principales: | Unlu, Ece, Cevikol, Alev, Bal, Burcu, Gonen, Emel, Celik, Ozlem, Kose, Gulşen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898546/ https://www.ncbi.nlm.nih.gov/pubmed/20613938 http://dx.doi.org/10.1590/S1807-59322010000600009 |
Ejemplares similares
-
Botulinum Toxin Treatment for Limb Spasticity in Childhood Cerebral Palsy
por: Pavone, Vito, et al.
Publicado: (2016) -
Consensus recommendations for botulinum toxin injections in the spasticity management of children with cerebral palsy during COVID-19 outbreak
por: YILMAZ YALÇINKAYA, Ebru, et al.
Publicado: (2021) -
Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy
por: Mirska, Anna, et al.
Publicado: (2018) -
Changes in Muscle Mass after Botulinum Toxin Injection in Children with Spastic Hemiplegic Cerebral Palsy
por: Lee, Dongwoo, et al.
Publicado: (2021) -
The Effects of Botulinum Toxin and Casting in Spastic Children With Cerebral Palsy: A Systematic Review and Meta-Analysis
por: Kumar, Deepak, et al.
Publicado: (2023)